Alcohol - Foe or friend?

South African Medical Journal

Volumn 95, Issue 9, 2005, Pages 648-654

  Blackhurst, Diane M ^a   Marais, A David ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; CATECHIN; FLAVONOID; MALVIDIN CHLORIDE GLUCOSIDE; PHENOL DERIVATIVE; QUERCETIN; RESVERATROL;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLIC BEVERAGE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BACTERICIDAL ACTIVITY; BEER; CARDIOVASCULAR RISK; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; COGNITION; DRINKING BEHAVIOR; FERMENTATION; FETAL ALCOHOL SYNDROME; HEALTH PROMOTION; HEALTH STATUS; HUMAN; LIFESTYLE; RED WINE; SOCIAL PROBLEM; SOUTH AFRICA; STROKE; WELLBEING;

ALCOHOL DRINKING; ALCOHOLISM; CARDIOVASCULAR DISEASES; ETHANOL; HEALTH; HUMANS; WINE;

EID: 26644438344     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Parry CDH. South Africa: alcohol today. Addiction 2005; 100: 426-429.
2. Viljoen D, Craig P, Hymbaugh K, Boyle C, Blount S. Fetal alcohol syndrome - South Africa, 2001. Morb Mortal Wkly Rep 2003; 52: 660-662.
3. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. Review of 97 bioavailablity studies. Am J Clin Nutr 2005; 81: suppl, 230S-242S.
4. Hines LM, Stampfer MJ, Ma J, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 2001; 344: 549-555.
5. Pearl R. Alcohol and Longevity. New York: Alfred A Knopf, 1926.
6. Renaud SC, Gueguen R, Schenker J, d'Houtaud A. Alcohol and mortality in middle-aged men from Eastern France. Epidemiology 1998; 9: 184-188.
7. Ruf J-C. Overview of epidemiological studies on wine, health and mortality. Drugs Exp Clin Res 2003; 29: 173-179.
8. Marmot MG. Alcohol and coronary heart disease. Int J Epidemiol 2001; 30: 724-729.
9. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526.
10. Ruitenberg A, van Swieten JC, Witteman JCM, Mehta KM, van Duijn CM. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 2002; 359: 281-286.
11. Feskanich D, Korrick SA, Greenspan SL, Rosen HN, Colditz GA. Moderate alcohol consumption and bone density among postmenopausal women. J Womens Health 1999; 8(1): 65-73.
12. Wannamethee SG, Shaper AG, Perry PJ, Alberti KGMM. Alcohol consumption and the incidence of type 2 diabetes. J Epidemiol Community Health 2002; 56: 542-548.
13. Ajani UA, Gaziano JM, Latufo PA, et al. Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 2000; 102: 500-505.
14. Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE, Rimm EB et al. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 2000; 102: 494-499.
15. Reynolds K, Lewis LB, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003; 289: 579-588.
16. Iso H, Baba S, Mannami T, et al. Alcohol consumption and risk of stroke among middle-aged men: the JPHC study cohort 1. Stroke 2004; 35: 1124-1129.
17. Burns J, Crozier A, Lean MEJ. Alcohol consumption and mortality: is wine different from other alcoholic beverages? Nutr Metab Cardiovasc Dis 2001; 11: 249-258.
18. Prescott E, Grønbæk M, Becker U, Sorensen TI. Alcohol intake and the risk of lung cancer: influence of type of alcoholic beverage. Am J Epidemiol 1999; 149: 463-470.
19. Barefoot JC, Gronbaek M, Feaganes jun. McPherson RS, Williams RB, Siegler IC. Alcoholic beverage preference, diet, and health habits in the UNC Alumni Heart Study. Am J Clin Nutr 2002; 76: 466-472.
20. Longnecker MP, Enger SM. Epidemiologic data on alcoholic beverage consumption and risk of cancer. Clin Chim Acta 1996; 246(1-2): 121-141.
21. Salaspuro MP. Alcohol consumption and cancer of the gastrointestinal tract. Best Practice and Research Clinical Gastroenterology 2003; 17: 679-694.
22. Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review Cancer Causes Control 1994; 5(1): 73-82.
23. Zhang Y, Kreger BE, Dorgan JF, Splansky GL, Cupples LA, Ellison RC. Alcohol consumption and risk of breast cancer: the Framingham Study revisited. Am J Epidemiol 1999; 149: 93-101.
24. Doll R. One for the heart. BMJ 1997; 315: 1664-1668.
25. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine or spirits? BMJ 1996; 312: 731-736.
26. Agewall S, Wright S, Doughty RN, Whalley GA, Duxbury M, Sharpe N. Does a glass of red wine improve endothelial function? Eur Heart J 2000; 21: 74-78.
27. Wallerath T, Poleo D, Li H, Förstermann U. Red wine increases the expression of human endothelial nitric oxide synthase. J Am Coll Cardiol 2003; 41: 471-478.
28. Fuhrman B, Volkova N, Suraski A, Aviram M. White wine with red wine-like properties: increased extraction of grape skin polyphenols improves the antioxidant capacity of the derived white wine. J Agric Food Chem 2003; 49: 3164-3168.
29. Sato M, Ray PS, Maulik G, et al. Myocardial protection with red wine extract. J Cardiovasc Pharmacol 2000; 35: 263-268.
30. Chopra M, Fitzsimons PEE, Strain JJ, Thurnham DI, Howard AN. Nonalcoholic red wine extract and quercetin inhibit LDL oxidation without affecting plasma antioxidant vitamin and carotenoid concentrations. Clin Chem 2000; 46: 1162-1170.
31. Guiraud A, de Lorgeril M, Boucher F, Berthonneche C, Rakotovao A, de Leiris J. Cardioprotective effect of chronic low dose ethanol drinking: insights into the concept of ethanol preconditioning. J Mol Cell Cardiol 2004; 36: 561-566.
32. Hashimoto M, Kim S, Eto S, et al. Effect of acute intake of red wine on flow-mediated vasodilation of the brachial artery. Am J Cardiol 2001; 88: 1457-1460.
33. Ellison RC, Zhang Y, Qureshi MM, Knox S, Arnett DK, Province MA. Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J 2005; 147: 529-535.
34. Hansen AS, Marckmann P, Dragsted LO, Finne Nielsen IL, Nielsen SE, Grønbaek M. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease. Eur J Clin Nutr 2005; 59: 449-455.
35. Pellegrini N, Pareti FI, Stabile F, Brusamolino A, Simonetti P. Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur J Clin Nutr 1996; 50: 209-213.
36. Russo P, Tedesco I, Russo M, Russo GL, Venezia A, Cicala C. Effects of de-alcoholated red wine and its phenolic fractions on platelet aggregation. Nutrition, Metabolism and Cardiovascular Diseases 2001; 11(1): 25-29.
37. van Golde PHM, Hart HC, van der Meijden BB, Kraaijenhagen RJ, Bouma BN, van de Wiel A. Aggregation of platelets is inhibited in vitro by red wine as well as its alcohol-deprived equivalent: ethanol is not a necessary component. Neth J Med 1997; 50: A28-A29.
38. Dixon JB, Dixon ME, O'Brien PE. Reduced plama homocysteine in obese red wine consumers: a potential contributor to reduced cardiovascular risk status. Eur J Clin Nutr 2002; 56: 608-614.
39. Marimón JM, Bujanda L, Gutiérrez-Stampa MA, Cosme A, Arenas JI. In vitro bactericidal effect of wine against Helicobacter pylori. Am J Gastroenterol 1998; 93: 1392.
40. Schriever C, Pendland SL, Mahady GB. Red wine, resveratrol, Chlamydia pneumoniae and the French Connection. Atherosclerosis 2003; 171: 380.
41. Brenner H, Rothenbacher D, Bode G, Adler G. Inverse graded relation between alcohol consumption and active infection with Helicobacter pylori. Am J Epidemiol 1999; 149: 571-576.
42. Damianaki A, Bakogeorgou E, Kampa M, et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 2000; 78: 429-441.
43. Kampa M, Hatzoglou A, Notas G, et al. Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer 2000; 37: 223-233.
44. Richter M, Ebermann R, Marian B. Quercetin-induced apoptosis in colorectal tumour cells: possible role of EGF receptor signalling. Nutr Cancer 2003; 34: 88-99.
45. Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425: 191-196.
46. Reddy KS. Cardiovascular disease in non-western countries. N Engl J Med 2004; 350: 2438-2440.